In summary, there is no single cell-based in vitro assay that clearly detected two clonally independent diseases and all but one indicated BCR::ABL1 emerging in pre-existing JAK2 V617Fpos MPN. This evidence concerns the gene ABL1 and myeloproliferative disorder.